Drug Shortage Report for ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS
Report ID | 65444 |
Drug Identification Number | 02466783 |
Brand name | ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS |
Common or Proper name | Atovaquone Proguanil Tablets |
Company Name | GLENMARK PHARMACEUTICALS CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | PROGUANIL HYDROCHLORIDE ATOVAQUONE |
Strength(s) | 100MG 250MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 12' |
ATC code | P01BB |
ATC description | ANTIMALARIALS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2018-10-23 |
Actual start date | 2018-10-23 |
Estimated end date | 2018-11-09 |
Actual end date | 2019-01-11 |
Shortage status | Resolved |
Updated date | 2019-01-12 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1600 STEELES AVE. W., SUITE 407 CONCORD, ONTARIO CANADA L4K 4M2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2019-01-12 | French | Compare |
v5 | 2019-01-07 | French | Compare |
v4 | 2019-01-07 | English | Compare |
v3 | 2018-10-24 | English | Compare |
v2 | 2018-10-23 | French | Compare |
v1 | 2018-10-23 | English | Compare |
Showing 1 to 6 of 6